menu Search
Johnson & Johnson

CATALENT CTS

Featured products of Catalent CTS
Imbruvica
Imbruvica cap 140 mg
ibrutinib
Packing/Price
120's90's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Distributed by Johnson & Johnson
Imbruvica
Imbruvica cap 140 mg
ibrutinib
Packing/Price
120's90's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.